Manufacturing Technologies Association

Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference

Wednesday, September 15, 2021 - 2:02pm

Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will participate in a round table discussion at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference presented by Maxim Group and hosed by M-Vest taking place Sept. 22, 2021.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will participate in a round table discussion at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference presented by Maxim Group and hosed by M-Vest taking place Sept. 22, 2021.
  • The discussion will focus on the topics surrounding Deliver, Manufacturing, & Technology and "What does it take to succeed in Psychedelics beyond drugs and clinics", beginning at 3:00 P.M.
  • Lobe Sciences is a life sciences company focused on psychedelic medicines.
  • This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts.